{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:17:57Z","timestamp":1793067477108,"version":"4.5.0"},"reference-count":163,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ccm.2019.05.003","type":"journal-article","created":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T07:10:02Z","timestamp":1562397002000},"page":"545-560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["Thoracic Manifestations of Rheumatoid Arthritis"],"prefix":"10.1016","volume":"40","author":[{"given":"Anthony J.","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah G.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachna","family":"Madan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy J.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul F.","family":"Dellaripa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6937","key":"10.1016\/j.ccm.2019.05.003_bib1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.003_bib2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/1529-0131(199904)42:3<415::AID-ANR4>3.0.CO;2-Z","article-title":"The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985","volume":"42","author":"Gabriel","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.003_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1185\/03007990903422307","article-title":"Societal cost of rheumatoid arthritis patients in the US","volume":"26","author":"Birnbaum","year":"2010","journal-title":"Curr Med Res Opin"},{"issue":"7","key":"10.1016\/j.ccm.2019.05.003_bib4","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","article-title":"The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study","volume":"73","author":"Cross","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.003_bib5","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/art.27425","article-title":"Is the incidence of rheumatoid arthritis rising? Results from Olmsted County, Minnesota, 1955-2007","volume":"62","author":"Myasoedova","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.ccm.2019.05.003_bib6","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/ard.62.8.722","article-title":"Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years","volume":"62","author":"Turesson","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.ccm.2019.05.003_bib7","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/ard.56.10.596","article-title":"Pulmonary function tests and high resolution computed tomography of the lungs in patients with rheumatoid arthritis","volume":"56","author":"Cortet","year":"1997","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.003_bib8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00296-004-0472-y","article-title":"Pulmonary involvement in rheumatoid arthritis","volume":"25","author":"Bilgici","year":"2005","journal-title":"Rheumatol Int"},{"issue":"1\u20132","key":"10.1016\/j.ccm.2019.05.003_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002960050093","article-title":"High resolution computed tomography of the lungs in patients with rheumatoid arthritis","volume":"19","author":"Demir","year":"1999","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.ccm.2019.05.003_bib10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00296-006-0234-0","article-title":"Radiological and functional assessment of pulmonary involvement in the rheumatoid arthritis patients","volume":"27","author":"Kanat","year":"2007","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.ccm.2019.05.003_bib11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1513\/pats.200703-045MS","article-title":"Rheumatoid lung disease","volume":"4","author":"Brown","year":"2007","journal-title":"Proc Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.rdc.2014.12.004","article-title":"Lung disease in rheumatoid arthritis","volume":"41","author":"Yunt","year":"2015","journal-title":"Rheum Dis Clin North Am"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.003_bib13","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.34344","article-title":"Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity?","volume":"64","author":"Demoruelle","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.ccm.2019.05.003_bib14","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.rmed.2012.06.020","article-title":"Prevalence of airway and parenchymal abnormalities in newly diagnosed rheumatoid arthritis","volume":"106","author":"Wilsher","year":"2012","journal-title":"Respir Med"},{"issue":"7","key":"10.1016\/j.ccm.2019.05.003_bib15","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.rmed.2012.03.006","article-title":"Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease","volume":"106","author":"Fischer","year":"2012","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.ccm.2019.05.003_bib16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s10067-009-1128-9","article-title":"Rheumatoid arthritis (RA)-specific autoantibodies in patients with interstitial lung disease and absence of clinically apparent articular RA","volume":"28","author":"Gizinski","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ccm.2019.05.003_bib17","doi-asserted-by":"crossref","first-page":"872120","DOI":"10.1155\/2011\/872120","article-title":"Rheumatoid arthritis-associated interstitial lung disease: diagnostic dilemma","volume":"2011","author":"Hamblin","year":"2011","journal-title":"Pulm Med"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.003_bib18","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.003_bib19","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3899\/jrheum.101133","article-title":"Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-based study","volume":"38","author":"Myasoedova","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"8","key":"10.1016\/j.ccm.2019.05.003_bib20","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/rheumatology\/keq035","article-title":"Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort","volume":"49","author":"Koduri","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.003_bib21","first-page":"62","article-title":"Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis","volume":"29","author":"Turesson","year":"2002","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.003_bib22","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","article-title":"Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study","volume":"62","author":"Bongartz","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.ccm.2019.05.003_bib23","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1136\/thx.56.8.622","article-title":"Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests","volume":"56","author":"Dawson","year":"2001","journal-title":"Thorax"},{"issue":"10","key":"10.1016\/j.ccm.2019.05.003_bib24","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/art.1780391014","article-title":"Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities","volume":"39","author":"Saag","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.003_bib25","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1164\/rccm.201004-0622OC","article-title":"Rheumatoid arthritis-interstitial lung disease-associated mortality","volume":"183","author":"Olson","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib26","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3899\/jrheum.171315.C1","article-title":"Rheumatoid arthritis-interstitial lung disease in the United States: prevalence, incidence, and healthcare costs and mortality","volume":"46","author":"Raimundo","year":"2019","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.ccm.2019.05.003_bib27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0009-9260(05)80183-7","article-title":"Comparative accuracy of high resolution computed tomography and chest radiography in the diagnosis of chronic diffuse infiltrative lung disease","volume":"44","author":"Padley","year":"1991","journal-title":"Clin Radiol"},{"issue":"2 Pt 1","key":"10.1016\/j.ccm.2019.05.003_bib28","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1164\/ajrccm.156.2.9609016","article-title":"Interstitial lung disease in recent onset rheumatoid arthritis","volume":"156","author":"Gabbay","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/archinternmed.2007.59","article-title":"Progressive preclinical interstitial lung disease in rheumatoid arthritis","volume":"168","author":"Gochuico","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccm.2019.05.003_bib30","doi-asserted-by":"crossref","first-page":"406927","DOI":"10.1155\/2013\/406927","article-title":"Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease","volume":"2013","author":"Chen","year":"2013","journal-title":"Clin Dev Immunol"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.003_bib31","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/ard.61.6.517","article-title":"Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis","volume":"61","author":"Dawson","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib32","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1148\/radiol.13130187","article-title":"Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern","volume":"270","author":"Assayag","year":"2014","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.ccm.2019.05.003_bib33","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1093\/rheumatology\/keu165","article-title":"Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study","volume":"53","author":"Kelly","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.003_bib34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1378\/chest.13-1394","article-title":"Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis","volume":"146","author":"Doyle","year":"2014","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.ccm.2019.05.003_bib35","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1164\/rccm.201504-0818OC","article-title":"Idiopathic pulmonary fibrosis in United States automated claims. Incidence, prevalence, and algorithm validation","volume":"192","author":"Esposito","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.003_bib36","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/BOR.0b013e32835f693f","article-title":"Extra-articular rheumatoid arthritis","volume":"25","author":"Turesson","year":"2013","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"10.1016\/j.ccm.2019.05.003_bib37","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/rheumatology\/ker258","article-title":"Pulmonary dysfunction, smoking, socioeconomic status and the risk of developing rheumatoid arthritis","volume":"50","author":"Bergstrom","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.ccm.2019.05.003_bib38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/ard.54.4.308","article-title":"High resolution computed tomography of the lung in lifelong non-smoking patients with rheumatoid arthritis","volume":"54","author":"Hassan","year":"1995","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib39","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1183\/13993003.00357-2015","article-title":"Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease","volume":"47","author":"Solomon","year":"2016","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.ccm.2019.05.003_bib40","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1164\/rccm.201411-1950OC","article-title":"Detection of rheumatoid arthritis-interstitial lung disease is enhanced by serum biomarkers","volume":"191","author":"Doyle","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.ccm.2019.05.003_bib41","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.rmed.2012.07.006","article-title":"Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis","volume":"106","author":"Mori","year":"2012","journal-title":"Respir Med"},{"issue":"8","key":"10.1016\/j.ccm.2019.05.003_bib42","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/annrheumdis-2012-203160","article-title":"Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease","volume":"73","author":"Giles","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.ccm.2019.05.003_bib43","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02314-2016","article-title":"Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis","volume":"49","author":"Juge","year":"2017","journal-title":"Eur Respir J"},{"issue":"16","key":"10.1016\/j.ccm.2019.05.003_bib44","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa1013660","article-title":"A\u00a0common MUC5B promoter polymorphism and pulmonary fibrosis","volume":"364","author":"Seibold","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib45","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.003_bib46","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.003_bib47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1148\/radiol.2321030174","article-title":"Rheumatoid arthritis-related lung diseases: CT findings","volume":"232","author":"Tanaka","year":"2004","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.003_bib48","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1378\/chest.127.6.2019","article-title":"Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease","volume":"127","author":"Lee","year":"2005","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.ccm.2019.05.003_bib49","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.rmed.2013.05.002","article-title":"Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD)","volume":"107","author":"Solomon","year":"2013","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.003_bib50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1148\/radiology.205.1.9314990","article-title":"Diffuse lung disease: diagnostic accuracy of CT in patients undergoing surgical biopsy of the lung","volume":"205","author":"Swensen","year":"1997","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.ccm.2019.05.003_bib51","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1378\/chest.116.5.1168","article-title":"The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study","volume":"116","author":"Raghu","year":"1999","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib52","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1164\/ajrccm.164.2.2101090","article-title":"Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis","volume":"164","author":"Hunninghake","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.003_bib53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1148\/radiology.171.1.2928513","article-title":"Chronic diffuse infiltrative lung disease: comparison of diagnostic accuracy of CT and chest radiography","volume":"171","author":"Mathieson","year":"1989","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib54","first-page":"158","article-title":"Rheumatoid arthritis associated interstitial lung disease: a review","volume":"74","author":"Assayag","year":"2014","journal-title":"Medicina (B Aires)"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.003_bib55","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1183\/09031936.00092309","article-title":"Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease","volume":"35","author":"Kim","year":"2010","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.003_bib56","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12890-016-0269-2","article-title":"Variable course of disease of rheumatoid arthritis-associated usual interstitial pneumonia compared to other subtypes","volume":"16","author":"Nurmi","year":"2016","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.003_bib57","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3109\/s10165-007-0004-1","article-title":"A\u00a0simultaneous onset of organizing pneumonia and rheumatoid arthritis, along with a review of the literature","volume":"18","author":"Mori","year":"2008","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.ccm.2019.05.003_bib58","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.1964.03070120036009","article-title":"Pulmonary disease associated with rheumatoid arthritis","volume":"189","author":"Brannan","year":"1964","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib59","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1756-185X.2009.01376.x","article-title":"Clinical and high resolution computed tomography characteristics of patients with rheumatoid arthritis lung disease","volume":"12","author":"Mohd Noor","year":"2009","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.003_bib60","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1186\/ar3037","article-title":"Respiratory symptoms and disease characteristics as predictors of pulmonary function abnormalities in patients with rheumatoid arthritis: an observational cohort study","volume":"12","author":"Pappas","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.ccm.2019.05.003_bib61","first-page":"325","article-title":"Pulmonary changes on high-resolution computed tomography of patients with rheumatoid arthritis and their association with clinical, demographic, serological and therapeutic variables","volume":"51","author":"Skare","year":"2011","journal-title":"Rev Bras Reumatol"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib62","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00330-003-2026-1","article-title":"Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis","volume":"14","author":"Biederer","year":"2004","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib63","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/1573398X11666150619184024","article-title":"The lung disease of rheumatoid arthritis","volume":"11","author":"Krause","year":"2015","journal-title":"Curr Respir Med Rev"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib64","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-0034-1371542","article-title":"Rheumatoid arthritis and lung disease: from mechanisms to a practical approach","volume":"35","author":"Lake","year":"2014","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib65","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","article-title":"An official ATS\/ERS\/JRS\/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline","volume":"192","author":"Raghu","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.ccm.2019.05.003_bib66","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1007\/s10067-016-3357-z","article-title":"Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease","volume":"35","author":"Zamora-Legoff","year":"2016","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.ccm.2019.05.003_bib67","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1136\/annrheumdis-2011-200702","article-title":"Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis","volume":"71","author":"Dixon","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"21","key":"10.1016\/j.ccm.2019.05.003_bib68","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis","volume":"366","author":"Raghu","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.003_bib69","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3899\/jrheum.111229","article-title":"A\u00a0prospective observational study of mycophenolate mofetil treatment in progressive diffuse cutaneous systemic sclerosis of recent onset","volume":"39","author":"Mendoza","year":"2012","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.003_bib70","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13075-016-1015-0","article-title":"Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis","volume":"18","author":"Shenoy","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.ccm.2019.05.003_bib71","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3899\/jrheum.121043","article-title":"Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease","volume":"40","author":"Fischer","year":"2013","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.ccm.2019.05.003_bib72","doi-asserted-by":"crossref","first-page":"R124","DOI":"10.1186\/ar2534","article-title":"Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies","volume":"10","author":"Nannini","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"25","key":"10.1016\/j.ccm.2019.05.003_bib73","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.ccm.2019.05.003_bib74","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/rheumatology\/39.12.1422","article-title":"Successful use of cyclosporin A for the treatment of acute interstitial pneumonitis associated with rheumatoid arthritis","volume":"39","author":"Ogawa","year":"2000","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib75","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3346\/jkms.2002.17.2.270","article-title":"Successful treatment of progressive rheumatoid interstitial lung disease with cyclosporine: a case report","volume":"17","author":"Chang","year":"2002","journal-title":"J\u00a0Korean Med Sci"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.003_bib76","first-page":"99","article-title":"B-cell depletion salvage therapy in rapidly progressive dermatomyositis related interstitial lung disease","volume":"168","author":"Eissa","year":"2016","journal-title":"J\u00a0La State Med Soc"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.003_bib77","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1183\/09031936.00163911","article-title":"Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy","volume":"40","author":"Keir","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2019.05.003_bib78","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4236\/ojra.2012.23011","article-title":"Open-label, pilot study of the safety and clinical effects of rituximab in patients with rheumatoid arthritis associated interstitial pneumonia","volume":"2","author":"Matteson","year":"2012","journal-title":"Open J Rheumatol Autoimmune Dis"},{"issue":"8","key":"10.1016\/j.ccm.2019.05.003_bib79","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/RHU.0000000000000084","article-title":"Abatacept therapy in rheumatoid arthritis with interstitial lung disease","volume":"20","author":"Mera-Varela","year":"2014","journal-title":"J\u00a0Clin Rheumatol"},{"key":"10.1016\/j.ccm.2019.05.003_bib80","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s13075-015-0835-7","article-title":"Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor alpha agents, a retrospective cohort study","volume":"17","author":"Curtis","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.003_bib81","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.semarthrit.2017.12.012","article-title":"Abatacept in patients with rheumatoid arthritis and interstitial lung disease: a national multicenter study of 63 patients","volume":"48","author":"Fernandez-Diaz","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.ccm.2019.05.003_bib82","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.healun.2014.01.858","article-title":"Survival and quality of life in rheumatoid arthritis-associated interstitial lung disease after lung transplantation","volume":"33","author":"Yazdani","year":"2014","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"5","key":"10.1016\/j.ccm.2019.05.003_bib83","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrrheum.2013.197","article-title":"The safety of biologic therapies in RA-associated interstitial lung disease","volume":"10","author":"Jani","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.003_bib84","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archotol.1975.00780350025006","article-title":"Rheumatoid nodules of the larynx","volume":"101","author":"Friedman","year":"1975","journal-title":"Arch Otolaryngol"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib85","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/ard.31.2.122","article-title":"Rheumatoid nodules of the vocal folds","volume":"31","author":"Webb","year":"1972","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ccm.2019.05.003_bib86","first-page":"103081","article-title":"Laryngeal manifestations of rheumatoid arthritis","volume":"2013","author":"Hamdan","year":"2013","journal-title":"Autoimmune Dis"},{"issue":"8","key":"10.1016\/j.ccm.2019.05.003_bib87","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/art.1780270806","article-title":"Laryngeal involvement in rheumatoid arthritis. A clinical, laryngoscopic, and computerized tomographic study","volume":"27","author":"Lawry","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.003_bib88","first-page":"974","article-title":"Upper airway obstruction as the sole manifestation of rheumatoid arthritis","volume":"19","author":"Guerra","year":"1992","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib89","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1148\/radiology.158.2.3941873","article-title":"Cricoarytenoiditis: CT assessment in rheumatoid arthritis","volume":"158","author":"Brazeau-Lamontagne","year":"1986","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.ccm.2019.05.003_bib90","first-page":"970","article-title":"Cricoarytenoid rheumatoid arthritis: an important consideration in aggressive lesions of the larynx","volume":"26","author":"Chen","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib91","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/rheumatology\/40.2.237","article-title":"Control of unremitting rheumatoid arthritis by the prolactin antagonist cabergoline","volume":"40","author":"Erb","year":"2001","journal-title":"Rheumatology (Oxford)"},{"issue":"5 Pt 1","key":"10.1016\/j.ccm.2019.05.003_bib92","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1164\/ajrccm.157.5.9710018","article-title":"Airways involvement in rheumatoid arthritis: clinical, functional, and HRCT findings","volume":"157","author":"Perez","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ccm.2019.05.003_bib93","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1183\/09031936.00091608","article-title":"Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis","volume":"33","author":"Devouassoux","year":"2009","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.003_bib94","first-page":"65","article-title":"Bronchiolitis obliterans organizing pneumonia in a patient with rheumatoid arthritis","volume":"65","author":"Pommepuy","year":"1998","journal-title":"Rev Rhum Engl Ed"},{"issue":"4","key":"10.1016\/j.ccm.2019.05.003_bib95","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.rmed.2004.09.001","article-title":"Improvement of refractory rheumatoid arthritis-associated constrictive bronchiolitis with etanercept","volume":"99","author":"Cortot","year":"2005","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.ccm.2019.05.003_bib96","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1378\/chest.10-2944","article-title":"Azithromycin in posttransplant bronchiolitis obliterans syndrome","volume":"139","author":"Vos","year":"2011","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.ccm.2019.05.003_bib97","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1164\/ajrccm.154.5.8912776","article-title":"Bronchiolar disease in rheumatoid arthritis","volume":"154","author":"Hayakawa","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.1016\/j.ccm.2019.05.003_bib98","first-page":"OE01","article-title":"Follicular bronchiolitis: a literature review","volume":"9","author":"Tashtoush","year":"2015","journal-title":"J\u00a0Clin Diagn Res"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.003_bib99","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1148\/radiology.212.3.r99se04637","article-title":"Follicular bronchiolitis: thin-section CT and histologic findings","volume":"212","author":"Howling","year":"1999","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.003_bib100","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.chest.2016.12.024","article-title":"Bronchiectasis rheumatoid overlap syndrome is an independent risk factor for mortality in patients with bronchiectasis: a multicenter cohort study","volume":"151","author":"De Soyza","year":"2017","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.003_bib101","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/rheumatology\/36.6.689","article-title":"Decreased survival in patients with co-existent rheumatoid arthritis and bronchiectasis","volume":"36","author":"Swinson","year":"1997","journal-title":"Br J Rheumatol"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.003_bib102","first-page":"1281","article-title":"Increased frequency of cystic fibrosis deltaF508 mutation in bronchiectasis associated with rheumatoid arthritis","volume":"13","author":"Puechal","year":"1999","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.003_bib103","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.semarthrit.2006.03.002","article-title":"Rheumatoid pleural effusion","volume":"35","author":"Balbir-Gurman","year":"2006","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.ccm.2019.05.003_bib104","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.4187\/respcare.02597","article-title":"Pleuro-pulmonary complications of rheumatoid arthritis","volume":"59","author":"Corcoran","year":"2014","journal-title":"Respir Care"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.003_bib105","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/ard.3.3.168","article-title":"Visceral lesions associated with rheumatoid arthritis","volume":"3","author":"Fingerman","year":"1943","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ccm.2019.05.003_bib106","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.7326\/0003-4819-51-6-1179","article-title":"The pleural and pulmonary complications of rheumatoid arthritis","volume":"51","author":"Horler","year":"1959","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.003_bib107","first-page":"395","article-title":"A\u00a0systematic controlled study of pulmonary abnormalities in rheumatoid arthritis","volume":"10","author":"Hyland","year":"1983","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.ccm.2019.05.003_bib108","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/03009748209098194","article-title":"Prevalence of pulmonary involvement in rheumatoid arthritis and its relationship to some characteristics of the patients. A radiological and clinical study","volume":"11","author":"Jurik","year":"1982","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.003_bib109","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3109\/03009748609092595","article-title":"Rheumatoid arthritis with pleural effusion includes a subgroup with autoimmune features and HLA-B8, Dw3 association","volume":"15","author":"Hakala","year":"1986","journal-title":"Scand J Rheumatol"},{"issue":"10","key":"10.1016\/j.ccm.2019.05.003_bib110","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00296-007-0322-9","article-title":"Pleural effusion associated with rheumatoid arthritis: what cell predominance to anticipate?","volume":"27","author":"Avnon","year":"2007","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.003_bib111","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/ard.26.6.467","article-title":"Rheumatoid pleuritis","volume":"26","author":"Walker","year":"1967","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib112","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5694\/j.1326-5377.1986.tb113669.x","article-title":"Cardiac rheumatoid nodules","volume":"144","author":"Ojeda","year":"1986","journal-title":"Med J Aust"},{"issue":"5","key":"10.1016\/j.ccm.2019.05.003_bib113","first-page":"770","article-title":"Lung biopsy in rheumatoid arthritis","volume":"131","author":"Yousem","year":"1985","journal-title":"Am Rev Respir Dis"},{"issue":"11","key":"10.1016\/j.ccm.2019.05.003_bib114","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1136\/bjo.52.11.853","article-title":"Still's disease and rheumatoid nodule of the sclera","volume":"52","author":"Lyne","year":"1968","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.003_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000372-198802000-00001","article-title":"Rheumatoid nodule and subcutaneous granuloma annulare. A comparative histologic study","volume":"10","author":"Patterson","year":"1988","journal-title":"Am J Dermatopathol"},{"issue":"10","key":"10.1016\/j.ccm.2019.05.003_bib116","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/1529-0131(199810)41:10<1783::AID-ART10>3.0.CO;2-W","article-title":"Pathogenic mechanisms in the rheumatoid nodule: comparison of proinflammatory cytokine production and cell adhesion molecule expression in rheumatoid nodules and synovial membranes from the same patient","volume":"41","author":"Wikaningrum","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib117","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/03009742.2010.509103","article-title":"The presence of rheumatoid nodules at early rheumatoid arthritis diagnosis is a sign of extra-articular disease and predicts radiographic progression of joint destruction over 5 years","volume":"40","author":"Nyhall-Wahlin","year":"2011","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.003_bib118","first-page":"179","article-title":"Clustering of extraarticular manifestations in patients with rheumatoid arthritis","volume":"35","author":"Turesson","year":"2008","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.003_bib119","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/ard.55.3.190","article-title":"Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study","volume":"55","author":"Voskuyl","year":"1996","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.003_bib120","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00005792-196811000-00003","article-title":"Pulmonary lesions and rheumatoid arthritis","volume":"47","author":"Walker","year":"1968","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.ccm.2019.05.003_bib121","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.ejrad.2015.07.008","article-title":"Intra-thoracic rheumatoid arthritis: imaging spectrum of typical findings and treatment related complications","volume":"84","author":"Chansakul","year":"2015","journal-title":"Eur J Radiol"},{"issue":"5","key":"10.1016\/j.ccm.2019.05.003_bib122","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5114\/reum.2015.55831","article-title":"Multiple pulmonary rheumatoid nodules","volume":"53","author":"Sargin","year":"2015","journal-title":"Reumatologia"},{"issue":"8","key":"10.1016\/j.ccm.2019.05.003_bib123","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1136\/annrheumdis-2011-200915","article-title":"Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab\/Rheumatoid Arthritis registry (AIR\/PR registry)","volume":"71","author":"Glace","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.ccm.2019.05.003_bib124","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s10067-015-3049-0","article-title":"Prevalence of dyslipidemia in Japanese patients with rheumatoid arthritis and effects of atorvastatin treatment","volume":"34","author":"Akiyama","year":"2015","journal-title":"Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.ccm.2019.05.003_bib125","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.3899\/jrheum.090030","article-title":"Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case series","volume":"36","author":"Toussirot","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.003_bib126","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/thx.8.1.29","article-title":"Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis","volume":"8","author":"Caplan","year":"1953","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.003_bib127","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejim.2010.02.004","article-title":"Rheumatoid pneumoconiosis (Caplan's syndrome)","volume":"21","author":"Schreiber","year":"2010","journal-title":"Eur J Intern Med"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.003_bib128","first-page":"393","article-title":"High prevalence of antinuclear antibodies in sandblasters' silicosis","volume":"113","author":"Jones","year":"1976","journal-title":"Am Rev Respir Dis"},{"issue":"7","key":"10.1016\/j.ccm.2019.05.003_bib129","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s00296-012-2659-y","article-title":"Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis","volume":"33","author":"Shahane","year":"2013","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.003_bib130","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ijcard.2007.04.084","article-title":"Pulmonary hypertension in rheumatoid arthritis--relation with the duration of the disease","volume":"127","author":"Udayakumar","year":"2008","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ccm.2019.05.003_bib131","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/03009740410005809","article-title":"Pulmonary hypertension in rheumatoid arthritis","volume":"33","author":"Keser","year":"2004","journal-title":"Scand J Rheumatol"},{"issue":"12","key":"10.1016\/j.ccm.2019.05.003_bib132","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/rheumatology\/39.12.1320","article-title":"Raised pulmonary artery pressures measured with Doppler echocardiography in rheumatoid arthritis patients","volume":"39","author":"Dawson","year":"2000","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.ccm.2019.05.003_bib133","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1136\/annrheumdis-2013-203380","article-title":"Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study","volume":"73","author":"Chung","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.003_bib134","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.33322","article-title":"Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events?","volume":"64","author":"Bacani","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"9990","key":"10.1016\/j.ccm.2019.05.003_bib135","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0140-6736(14)61704-9","article-title":"Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"386","author":"Singh","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ccm.2019.05.003_bib136","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.semarthrit.2013.09.005","article-title":"Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature review","volume":"43","author":"Roubille","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.003_bib137","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0272-5231(03)00138-2","article-title":"Pathologic characteristics of drug-induced lung disease","volume":"25","author":"Flieder","year":"2004","journal-title":"Clin Chest Med"},{"issue":"7","key":"10.1016\/j.ccm.2019.05.003_bib138","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/ard.2008.093690","article-title":"Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research","volume":"68","author":"Salliot","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.003_bib139","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10067-011-1758-6","article-title":"How common is methotrexate pneumonitis? A large prospective study investigates","volume":"31","author":"Sathi","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.003_bib140","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/rheumatology\/41.3.262","article-title":"Investigation of the chronic pulmonary effects of low-dose oral methotrexate in patients with rheumatoid arthritis: a prospective study incorporating HRCT scanning and pulmonary function tests","volume":"41","author":"Dawson","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.003_bib141","first-page":"51","article-title":"Incidence, prevalence and possible risk factors for pneumonitis in patients with rheumatoid arthritis receiving methotrexate","volume":"21","author":"Carroll","year":"1994","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib142","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1034\/j.1399-3003.2000.15b25.x","article-title":"Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients","volume":"15","author":"Imokawa","year":"2000","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.003_bib143","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1046\/j.1468-3083.2001.t01-1-00223.x","article-title":"Pneumonitis complicating methotrexate therapy for pustular psoriasis","volume":"15","author":"Ameen","year":"2001","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.ccm.2019.05.003_bib144","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7326\/0003-4819-127-5-199709010-00003","article-title":"Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group","volume":"127","author":"Alarcon","year":"1997","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/rheumatology\/keg466","article-title":"Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis","volume":"43","author":"Saravanan","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.ccm.2019.05.003_bib146","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1378\/chest.109.4.933","article-title":"Pulmonary function in patients receiving long-term low-dose methotrexate","volume":"109","author":"Cottin","year":"1996","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.003_bib147","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0049-0172(87)90021-7","article-title":"Pulmonary disease during the treatment of rheumatoid arthritis with low dose pulse methotrexate","volume":"16","author":"Carson","year":"1987","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib148","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.reuma.2011.12.008","article-title":"Interstitial lung disease related to rheumatoid arthritis: evolution after treatment","volume":"8","author":"Rojas-Serrano","year":"2012","journal-title":"Reumatol Clin"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib149","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/art.37723","article-title":"Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis","volume":"65","author":"Wasko","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"10.1016\/j.ccm.2019.05.003_bib150","doi-asserted-by":"crossref","first-page":"ii2","DOI":"10.1136\/annrheumdis-2013-203348","article-title":"Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012","volume":"72","author":"Furst","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.ccm.2019.05.003_bib151","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.amjmed.2010.11.028","article-title":"Pulmonary disorders induced by monoclonal antibodies in patients with rheumatologic autoimmune diseases","volume":"124","author":"Ramos-Casals","year":"2011","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.003_bib152","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/ard.2009.120626","article-title":"Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register","volume":"69","author":"Dixon","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 4","key":"10.1016\/j.ccm.2019.05.003_bib153","doi-asserted-by":"crossref","first-page":"iv42","DOI":"10.1136\/ard.2005.042499","article-title":"The British Society for Rheumatology biologics register","volume":"64","author":"Watson","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ccm.2019.05.003_bib154","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.semarthrit.2010.11.002","article-title":"Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases","volume":"41","author":"Perez-Alvarez","year":"2011","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.ccm.2019.05.003_bib155","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3899\/jrheum.120906","article-title":"Safety of abatacept administered intravenously in treatment of rheumatoid arthritis: integrated analyses of up to 8 years of treatment from the abatacept clinical trial program","volume":"40","author":"Weinblatt","year":"2013","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.ccm.2019.05.003_bib156","doi-asserted-by":"crossref","first-page":"27178","DOI":"10.3402\/ecrj.v2.27178","article-title":"Rituximab-induced interstitial lung disease: five case reports","volume":"2","author":"Naqibullah","year":"2015","journal-title":"Eur Clin Respir J"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.003_bib157","first-page":"29","article-title":"Severe adverse drug reactions to biological disease-modifying anti-rheumatic drugs in elderly patients with rheumatoid arthritis in clinical practice","volume":"36","author":"Leon","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.ccm.2019.05.003_bib158","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1183\/09031936.02.00267402","article-title":"Sulphasalazine and lung toxicity","volume":"19","author":"Parry","year":"2002","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.003_bib159","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/rheumatology\/29.3.222","article-title":"Fibrosing alveolitis due to sulphasalazine in a patient with rheumatoid arthritis","volume":"29","author":"Boyd","year":"1990","journal-title":"Br J Rheumatol"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.003_bib160","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10067-003-0848-5","article-title":"Bronchiolitis obliterans organizing pneumonia associated with sulfasalazine in a patient with rheumatoid arthritis","volume":"23","author":"Ulubas","year":"2004","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.003_bib161","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00869-2018","article-title":"Predicting outcomes in rheumatoid arthritis related interstitial lung disease","volume":"53","author":"Jacob","year":"2019","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ccm.2019.05.003_bib162","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/17476348.2019.1553620","article-title":"Existing and emerging biomarkers for disease progression in idiopathic pulmonary fibrosis","volume":"13","author":"Inchingolo","year":"2019","journal-title":"Expert Rev Respir Med"},{"issue":"3","key":"10.1016\/j.ccm.2019.05.003_bib163","doi-asserted-by":"crossref","first-page":"L487","DOI":"10.1152\/ajplung.00301.2018","article-title":"Pro-fibrotic effects of IL-17A and elevated IL-17RA in IPF and RA-ILD support a direct role for IL-17A\/IL-17RA in human fibrotic interstitial lung disease","volume":"316","author":"Zhang","year":"2019","journal-title":"Am J Physiol Lung Cell Mol Physiol"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523119300310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523119300310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:56:47Z","timestamp":1759453007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523119300310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":163,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0272523119300310"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2019.05.003","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thoracic Manifestations of Rheumatoid Arthritis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2019.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}